The tumor cells showed positive immunoreactivity for synaptophysin, chromogranin A, ER, PgR, and bcl-2 (Figures 5 and 6) and negative (or almost negative) immunoreactivity for HER-2. The gene discussed is ERBB2; the disease is neoplasm.